Cytomegalovirus infection in hematologic malignancy settings other than the allogeneic transplant.

@article{Marchesi2018CytomegalovirusII,
  title={Cytomegalovirus infection in hematologic malignancy settings other than the allogeneic transplant.},
  author={Francesco Marchesi and Fulvia Pimpinelli and Fabrizio Ensoli and Andrea Mengarelli},
  journal={Hematological oncology},
  year={2018},
  volume={36 2},
  pages={381-391}
}
Cytomegalovirus (CMV) infection in clinical settings other than the allogeneic transplant represents a poorly explored issue. Thus, we performed a comprehensive review of the medical literature about CMV infection in patients undergoing autologous hematopoietic stem cell transplant and in other nontransplant-related hematologic patients. In autologous hematopoietic stem cell transplant, a CMV reactivation is reported to occur in up to 41% of CMV seropositive patients, when a prospective… CONTINUE READING